Pharmaceutical Retailers
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
HITI
1
High Tide
HITI
$241M
| $241M | $2.70 | 6.3% |
|
| 2 |
2
PetMed Express
PETS
$34.7M
| $34.7M | $1.60 | 1.23% |
|
| 3 |
SCNX
3
Scienture Holdings
SCNX
$13.6M
| $13.6M | $0.3305 | 0.3% |
|
| 4 |
POM
4
Pomdoctor Ltd
POM
$7.42M
| $7.42M | $0.8004 | 6.06% |
|
| 5 |
RDGT
5
Ridgetech Inc
RDGT
$3.12M
| $3.12M | $0.8599 | 5.38% |
|
Pharmaceutical Retailers Stocks at a Glance
Pharmaceutical retailers dispense prescription drugs alongside health and convenience merchandise. Prescription volumes are defensive, but reimbursement pressure squeezes pharmacy margins, pushing chains toward clinics, healthcare services, and front-of-store profitability.
There are 5 Pharmaceutical Retailers industry stocks tracked by Wall St. Rank, worth a combined $299M.
The largest by market cap are High Tide (HITI) at $241M, PetMed Express (PETS) at $34.7M and Scienture Holdings (SCNX) at $13.6M.
Among institutional investors, Scienture Holdings (SCNX) drew the most net new fund positions in Q2 2026: 4 funds opened new positions, taking total fund holders up 2 (14%) quarter-over-quarter.
- Combined market cap: $299M across 5 stocks.
- Largest constituent: High Tide (HITI), $241M market cap.
- Most net new fund positions in Q2 2026: Scienture Holdings (SCNX), +2 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.